Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Psychiatry

• Publication date

  2007-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/APPI.AJP.2007.07030454PMID 17728420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.

  2007cited by this paper
• The sales of antidepressants and suicide rates in Norway and its counties 1980-2004.

  2007cited by this paper
• Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.

  2007cited by this paper
• Suicide attempts among patients starting depression treatment with medications or psychotherapy.

  2007cited by this paper
• Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.

  2007cited by this paper
• Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.

  2007cited by this paper
• Antidepressants and Suicide Risk in the United States, 1985–1999Grunebaum MF, Ellis SP, Li S, et al (New York State Psychiatric Inst; Columbia Univ, New York) J Clin Psychiatry 65:1456–1462, 2004§

  2006cited by this paper
• ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth

  2006cited by this paper
• Suicidal risk in antidepressant drug trials.

  2006cited by this paper
• The relationship between antidepressant prescription rates and rate of early adolescent suicide.

  2006cited by this paper
• Suicide risk during antidepressant treatment.

  2006cited by this paper
• Anti-depressants, suicide, and drug regulation.

  2005influential reference
• Suicide prevention strategies: a systematic review.

  2005cited by this paper
• The relationship between antidepressant medication use and rate of suicide.

  2005influential reference
• Antidepressant Treatment and Risk of Suicide Attempt by Adolescents with Major Depressive Disorder

  2004cited by this paper
• Psychosocial Treatment of Youth Suicide: A Systematic Review of the Research

  2004cited by this paper
• Antidepressants and suicide risk in the United States, 1985-1999.

  2004cited by this paper
• Relationship between antidepressant medication treatment and suicide in adolescents.

  2003cited by this paper
• Observational Studies

  2003cited by this paper
• Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004.

  2003cited by this paper
• Suicide prevention — a medical breakthrough?

  2000influential reference
• Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior.

  1999cited by this paper
• The utilization of antidemessants — a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992‐1994

  1997cited by this paper
• Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study.

  1996cited by this paper
• Mental disorders in young and middle aged men who commit suicide

  1995cited by this paper
• Suicide and the use of antidepressants Drug treatment of depression is inadequate

  1994cited by this paper
• Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population‐based drug database in Sweden

  1992cited by this paper
• San Diego Suicide Study. III. Relationships between diagnoses and stressors.

  1988cited by this paper
• A Hundred Cases of Suicide: Clinical Aspects

  1974cited by this paper
• A Hundred Cases of Suicide: Clinical Aspects

  1974cited by this paper
• A study of suicide in the Seattle area.

  1960cited by this paper
• Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides.

  1959cited by this paper

• Somatostatin-expressing neurons in the zona incerta regulate chronic stress response and modulate depression-like behaviors.

  2026cites this paper
• Drug-related suicidal events in children and teenagers: Age-stratified insights from FAERS.

  2026cites this paper
• Bayesian Multiple Testing for Suicide Risk in Pharmacoepidemiology: Leveraging Co-Prescription Patterns

  2026cites this paper
• Doctor Decision-Making and Patient Outcomes

  2026cites this paper
• The effectiveness of behavioral activation and antidepressant medication on the reduction of suicidality in patients with major depressive disorder

  2025cites this paper
• Revolutionizing Huntington’s Disease Treatment: Breakthroughs in AAV-Mediated Gene Therapy

  2025cites this paper
• Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial

  2025cites this paper
• Examining Antidepressant Side Effect Burden in Youth: The FIBSER-C Scale in the Texas Youth Depression and Suicide Research Network Study

  2025cites this paper
• Suicidal thoughts and behaviors in adolescents with mood disorders: Insights from a nationally representative sample.

  2025cites this paper
• Enhancing readability of USFDA patient communications through large language models: a proof-of-concept study

  2024cites this paper
• Suicide, Stimulants, and Selective Serotonin Reuptake Inhibitors: A Retrospective Chart Review

  2024cites this paper
• What to Know Before Prescribing Antidepressants to Depressed Youths: A Focus on the Black Box Warning

  2024cites this paper
• Activation syndrome in children and adolescents treated with selective serotonin reuptake inhibitors.

  2024cites this paper
• GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review.

  2024cites this paper
• Navigating grey areas in HIV and mental health implementation science

  2024cites this paper
• Adolescent suicide: a major mental health issue in pediatric care.

  2023cites this paper
• Determining the Burden of Suicidal Behaviors Using the DALY Approach: A Case Study in Iran (2018-2021)

  2023cites this paper
• Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases

  2023cites this paper
• Antiepileptic drugs and the risk of suicide in patients with epilepsy

  2023cites this paper
• GluN2A mediates ketamine-induced rapid antidepressant-like responses

  2023cites this paper
• Current and Possible Future Therapeutic Options for Huntington’s Disease

  2022cites this paper
• FDA Black Box Warning for SSRI: Reexamining the Role of High-Functioning Autism as a Confounder

  2022cites this paper
• Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review.

  2022cites this paper
• Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial

  2022cites this paper
• Controversies In The Pharmacotherapy Of Adolescent Depression.

  2022cites this paper
• Black-Box Warnings: Their Consequences and how We Should Approach Them

  2022cites this paper
• Síndrome de Activación en Niños y Adolescentes Tratados con Inhibidores Selectivos de la Recaptación de Serotonina

  2022cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders

  2022cites this paper
• Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy.

  2022cites this paper
• Salud mental en la adolescencia (I). Ansiedad y depresión

  2022cites this paper
• Practical and Ethical Issues in Pediatric Psychopharmacology: Introductory Considerations

  2021cites this paper
• The Use of Real‐World Data to Assess the Impact of Safety‐Related Regulatory Interventions

  2021cites this paper
• Antidepressants and Black Box Warning: Duty to Inform or Unintended Consequence of Cautious Response

  2021cites this paper
• The effect of combined sertraline and positive psychotherapy on hopelessness and suicidal ideation among patients with major depressive disorder: a randomized controlled trial

  2021cites this paper
• The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.

  2021cites this paper
• Children and adolescents

  2021cites this paper
• Retrospective analysis of adverse events associated with non-stimulant ADHD medications reported to the united states food and drug administration.

  2021cites this paper
• Pharmacological Treatment of Suicidality in Affective and Psychotic Disorders

  2021cites this paper
• Suicidal Ideation Among Adolescents—The Role of Sexual Abuse, Depression, and Impulsive Behavior

  2021cites this paper
• A Critique on Psychiatric Inpatient Admissions for Suicidality in Youth.

  2021cites this paper
• Psychopharmaka

  2021cites this paper
• Information shocks and pharmaceutical firms' marketing efforts: Evidence from the Chantix black box warning removal.

  2021cites this paper
• Single-arm Pilot Trial of Hatha Yoga for Adolescents with Depression

  2021cites this paper
• Identifying the effects of scientific information and recommendations on physicians' prescribing behavior.

  2021influential citation
• Depression and Suicide in Adolescents

  2021cites this paper
• Antidepressant Like Effect of Ascorbic Acid in Mice: Possible Involvement of NO-sGC-cGMP Signaling

  2021cites this paper
• Current and Novel Psychopharmacological Drugs for Anxiety Disorders.

  2020cites this paper
• Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified

  2020influential citation
• Risk Assessment and Management

  2020cites this paper
• Economics of Suicide

  2020cites this paper
• Increases in Suicide Deaths Among Adolescents and Young Adults Following US Food and Drug Administration Antidepressant Boxed Warnings and Declines in Depression Care

  2020cites this paper
• PRE AND POST-OPERATIVE DENTAL PAIN AND ANXIETY IN PATIENTS UNDERGOING ROUTINE DENTAL EXTRACTION, PESHAWAR

  2020cites this paper
• New generation antidepressants for depression in children and adolescents: a network meta-analysis.

  2020cites this paper
• Suicide Associated with Risk Factors in Patients Suffering from Depression

  2020cites this paper
• Employment effects of healthcare policy: Evidence from the 2007 FDA black box warning on antidepressants.

  2020influential citation
• Drugs to Treat Depression.

  2020cites this paper
• Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified

  2020cites this paper
• Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in China.

  2020cites this paper
• Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends

  2020cites this paper
• Policy and Practice Innovations to Improve Prescribing of Psychoactive Medications for Children.

  2020cites this paper
• Psychopharmaka

  2020cites this paper
• Psychotropic Drug Treatment in Childhood and Adolescence

  2020cites this paper
• Pharmacological Approaches in Child and Adolescent Mental Health

  2020cites this paper
• Antidepressant Prescriptions, Including Tricyclics, Continue to Increase in Canadian Children

  2019cites this paper
• When ignorance is bliss: Intentional agnosticism in drug approval.

  2019cites this paper
• Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning

  2019cites this paper
• Existence of Notoriety Bias in FDA Adverse Event Reporting System Database and Its Impact on Signal Strength

  2019cites this paper
• Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study

  2019cites this paper
• Suicides in Greece before and during the period of austerity by sex and age group: Relationship to unemployment and economic variables.

  2019cites this paper
• Incidence of suicidal behaviour and violent crime following antidepressant medication: a Danish cohort study

  2019cites this paper
• Pediatric firearm-related traumatic brain injury in United States trauma centers.

  2019cites this paper
• Antidepressants for Pediatric Patients.

  2019cites this paper
• Depressive disorders: Defi nitions, contexts, differential diagnosis, neural correlates and clinical strategies

  2019cites this paper
• Pharmacological Interventions

  2019cites this paper
• Age and Birth Cohort–Adjusted Rates of Suicide Mortality Among US Male and Female Youths Aged 10 to 19 Years From 1999 to 2017

  2019cites this paper
• Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications

  2019cites this paper
• Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature

  2019cites this paper
• Traumatic Brain Injury and Suicidal Behavior: A Review

  2019cites this paper
• Association Between Parental Medical Claims for Opioid Prescriptions and Risk of Suicide Attempt by Their Children.

  2019cites this paper
• On the Effects of Serotonin Reuptake Inhibitors in Major Depression

  2019cites this paper
• Antidepressants and Suicidality—Controversies and Possible Mechanisms

  2019cites this paper
• Psychopharmaka

  2019cites this paper
• Serotonin and Norepinephrine Reuptake Inhibitors.

  2019cites this paper
• Universal Suicide Risk Screening in the Parkland Health and Hospital System: Evaluation of the Parkland Algorithm for Suicide Screening

  2019cites this paper
• Suicidal patients presenting to secondary and tertiary emergency departments and referral to a psychiatrist: a population-based descriptive study from Japan

  2018cites this paper
• Anxiety and Mood Disorders

  2018cites this paper
• Antidepressants in paediatric depression: do not look back in anger but around in awareness

  2018cites this paper
• Suicide in Children

  2018cites this paper
• Prävention oder Promotion?

  2018cites this paper
• Screening for Depression in Pediatric Primary Care

  2018cites this paper
• Prescription d’antidépresseurs chez les enfants et les adolescents

  2018cites this paper
• Major depressive disorder in children and adolescents

  2018cites this paper
• Counter-Point: Staying Honest When Policy Changes Backfire

  2018cites this paper
• Regional Variations in Suicide and Undetermined Death Rates among Adolescents across Canada.

  2018cites this paper
• Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement

  2018cites this paper
• Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA

  2018cites this paper
• Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents

  2018cites this paper
• Positive Antidepressant Pharmacotherapy in Reducing Suicide Morbidity and Mortality in Unipolar Depression

  2018cites this paper
• Biomarqueurs dans deux troubles des conduites bien caractérisés : trouble des conduites alimentaires et trouble des conduites suicidaires

  2018cites this paper
• The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin

  2017cites this paper